Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Journal of the Medical Association for Prevention of War
|
June 1, 1983
Excerpts from the report of the chairman, Australian branch of MAPW annual general meeting, 16 Oct 1982
Richard Kefford
Immunotherapy
|
May 21, 2016
PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges
Jenny Lee, Richard Kefford, Matteo Carlino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2013
Reply to K.S. Wilson et al
Antoni Ribas, Axel Hauschild, Richard Kefford
Australian Family Physician
|
December 8, 2005
Locally advanced and inflammatory breast cancer
Verity Ahern, Meagan Brennan, Owen Ung, et al.
The Australasian Journal of Dermatology
|
February 22, 2013
Intravascular metastatic melanoma: a difficult diagnosis
Samer Ghattas, Julie Howle, Wei Wang, et al.
Respirology Case Reports
|
July 18, 2019
<i>Pneumocystis jirovecii</i> in a patient on dose-dense chemotherapy for early breast cancer
Chloe Khoo, Jenny Gilchrist, Jonathan Philip Williamson, et al.
The Australasian Journal of Dermatology
|
August 28, 2014
Diffuse melanosis cutis in the setting of BRAF(V600E) mutant melanoma and treatment with targeted therapies
Rashi Minocha, Richard Kefford, Pablo Uribe, et al.
Oncogenesis
|
September 22, 2018
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Oncogenesis
|
April 10, 2026
Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Melanoma Research
|
February 6, 2003
Patterns of metastases in familial and non-familial melanoma
Joanne Hornbuckle, Gordana Culjak, Elizabeth Jarvis, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Journal of the Medical Association for Prevention of War
|
June 1, 1983
Excerpts from the report of the chairman, Australian branch of MAPW annual general meeting, 16 Oct 1982
Richard Kefford
Immunotherapy
|
May 21, 2016
PD-1 and PD-L1 inhibitors in melanoma treatment: past success, present application and future challenges
Jenny Lee, Richard Kefford, Matteo Carlino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2013
Reply to K.S. Wilson et al
Antoni Ribas, Axel Hauschild, Richard Kefford
Australian Family Physician
|
December 8, 2005
Locally advanced and inflammatory breast cancer
Verity Ahern, Meagan Brennan, Owen Ung, et al.
The Australasian Journal of Dermatology
|
February 22, 2013
Intravascular metastatic melanoma: a difficult diagnosis
Samer Ghattas, Julie Howle, Wei Wang, et al.
Respirology Case Reports
|
July 18, 2019
<i>Pneumocystis jirovecii</i> in a patient on dose-dense chemotherapy for early breast cancer
Chloe Khoo, Jenny Gilchrist, Jonathan Philip Williamson, et al.
The Australasian Journal of Dermatology
|
August 28, 2014
Diffuse melanosis cutis in the setting of BRAF(V600E) mutant melanoma and treatment with targeted therapies
Rashi Minocha, Richard Kefford, Pablo Uribe, et al.
Oncogenesis
|
September 22, 2018
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Oncogenesis
|
April 10, 2026
Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Melanoma Research
|
February 6, 2003
Patterns of metastases in familial and non-familial melanoma
Joanne Hornbuckle, Gordana Culjak, Elizabeth Jarvis, et al.
Page
of 7